Journal of Traditional Chinese Medicine ›› 2022, Vol. 42 ›› Issue (2): 227-233.DOI: 10.19852/j.cnki.jtcm.20220126.001
• Research Articles • Previous Articles Next Articles
Effects of moxibustion at bilateral Feishu (BL13) and Xinshu (BL15) combined with benazepril on myocardial cells apoptosis index and apoptosis-related proteins cytochrome c and apoptosis-inducing factor in rats with chronic heart failure
WANG Wei1, LI Qingling1, MA Qiang2, XIA Ran2, GAO Bing2, WANG Yi3, WANG Jing4(
)
- 1 College of Chinese Medicine, Anhui University of Chinese Medicine, Hefei 230012, China
2 Graduate school, Anhui University of Chinese Medicine, Hefei 230012, China
3 College of Acupuncture and Massage, Anhui University of Chinese Medicine, Hefei 230012, China
4 Xin’an Medical Key Laboratory; Anhui University of Chinese Medicine, Hefei 230012, China
-
Received:2021-07-22Accepted:2021-10-14Online:2022-01-26Published:2022-01-26 -
Contact:WANG Jing -
About author:Prof. WANG Jing, Xin’an Medical Key Laboratory; Anhui University of Chinese Medicine, Hefei 230012, China. wangjing2161@126.com, Telephone: +86-13955189703
-
Supported by:National Natural Science Foundation of China: Mechanism of Protective Effects of Moxibustion on Regulating mTOR Signaling Pathway and Inhibiting Autophagy in Rats(81574084);Key Research and Development Program of Anhui Province: Mechanism and Clinical Application of Moxibustion in that Treatment of Chronic Heart Failure(202004j07020045);Open Fund Project of Key Laboratory of Xin’an Medical Education Ministry: Effect of Moxibustion on Myocardial Cell Energy Metabolism in Chronic Heart Failure Patients Based on Xin’an Physician's Theory of Strengthening the Foundation and Cultivating the Original(2020xayx07);Key Natural Science Projects of Anhui Provincial Education Department: Mechanism of Moxibustion Against CHF Fibrosis Based on miR-21/PTEN/mTOR Signaling Pathway-mediated Regulation of Autophagy in Myocardial Cells by circPAN3(KJ2021A0570)
Cite this article
WANG Wei, LI Qingling, MA Qiang, XIA Ran, GAO Bing, WANG Yi, WANG Jing. Effects of moxibustion at bilateral Feishu (BL13) and Xinshu (BL15) combined with benazepril on myocardial cells apoptosis index and apoptosis-related proteins cytochrome c and apoptosis-inducing factor in rats with chronic heart failure[J]. Journal of Traditional Chinese Medicine, 2022, 42(2): 227-233.
share this article
Figure 1 Model identification A: echocardiography in normal group; B: echocardiography in model-I group; C: EF between normal group and model-I group; D: FS between normal group and model-I group. Normal group: rats were fed normally (n = 3); Model-I group: CHF rats were fed normally without treatment (n = 3). aP < 0.01, compared with normal group.
Figure 1 Model identification A: echocardiography in normal group; B: echocardiography in model-I group; C: EF between normal group and model-I group; D: FS between normal group and model-I group. Normal group: rats were fed normally (n = 3); Model-I group: CHF rats were fed normally without treatment (n = 3). aP < 0.01, compared with normal group.
Figure 2 Comparisons of echocardiogram indexes in different groups A-E, G-K: echocardiography in different groups; F: echocardiogram indexes in different groups; F1: EF in different groups; F2: FS in different groups; F3: SV in different groups; L: HR in different groups. Normal group: rats were fed normally without intervention (n = 10). Model group: CHF rats were fed normally without treatment (n = 6). Moxibustion group (abbreviate as Mox group in F1-F3, L): CHF rats were performed for 20 min at Feishu (BL13) and Xinshu (BL15) with moxa sticks daily for 3 weeks (n = 8); benazepril group (abbreviate as Ben group in F1-F3, L): CHF rats were administered with benazepril at a daily dose of 2 mg/kg for 3 weeks (n = 7); aibei group: CHF rats were administered with benazepril at a daily dose of 2 mg/kg, and performed for 20 min at Feishu (BL13) and Xinshu (BL15) with moxa sticks daily for 3 weeks (n = 9). aP < 0.01, compared with normal group; bP < 0.01, compared with model group; cP < 0.05, dP < 0.01, compared with Aibei group.
Figure 2 Comparisons of echocardiogram indexes in different groups A-E, G-K: echocardiography in different groups; F: echocardiogram indexes in different groups; F1: EF in different groups; F2: FS in different groups; F3: SV in different groups; L: HR in different groups. Normal group: rats were fed normally without intervention (n = 10). Model group: CHF rats were fed normally without treatment (n = 6). Moxibustion group (abbreviate as Mox group in F1-F3, L): CHF rats were performed for 20 min at Feishu (BL13) and Xinshu (BL15) with moxa sticks daily for 3 weeks (n = 8); benazepril group (abbreviate as Ben group in F1-F3, L): CHF rats were administered with benazepril at a daily dose of 2 mg/kg for 3 weeks (n = 7); aibei group: CHF rats were administered with benazepril at a daily dose of 2 mg/kg, and performed for 20 min at Feishu (BL13) and Xinshu (BL15) with moxa sticks daily for 3 weeks (n = 9). aP < 0.01, compared with normal group; bP < 0.01, compared with model group; cP < 0.05, dP < 0.01, compared with Aibei group.
Table 1 Comparisons of hemodynamic indices in different groups ($\bar{x}±s$)
| Group | n | CO (mL/ min) | LVSP (kPa) | LVEDP (kPa) |
|---|---|---|---|---|
| Normal | 10 | 34.867±1.420 | 23.683±1.170 | 0.581±0.020 |
| Model | 6 | 20.143±1.301a | 12.431±1.230a | 1.682±0.060a |
| Moxibustion | 8 | 28.373±0.670bd | 18.403±0.410bd | 1.083±0.032bd |
| Benazepril | 7 | 25.627±2.710bd | 17.471±0.720bd | 1.123±0.031bd |
| Aibei | 9 | 32.707±1.650b | 20.821±0.820b | 0.823±0.040b |
Table 1 Comparisons of hemodynamic indices in different groups ($\bar{x}±s$)
| Group | n | CO (mL/ min) | LVSP (kPa) | LVEDP (kPa) |
|---|---|---|---|---|
| Normal | 10 | 34.867±1.420 | 23.683±1.170 | 0.581±0.020 |
| Model | 6 | 20.143±1.301a | 12.431±1.230a | 1.682±0.060a |
| Moxibustion | 8 | 28.373±0.670bd | 18.403±0.410bd | 1.083±0.032bd |
| Benazepril | 7 | 25.627±2.710bd | 17.471±0.720bd | 1.123±0.031bd |
| Aibei | 9 | 32.707±1.650b | 20.821±0.820b | 0.823±0.040b |
Figure 3 Comparisons of myocardial cells apoptosis in different groups A-E: TUNEL staining in different groups (×200); F: myocardial cells apoptosis index in different groups. Normal group: rats were fed normally without intervention (n = 10); model group: CHF rats were fed normally without treatment (n = 6); moxibustion group (abbreviate as Mox group in F): CHF rats were performed for 20 min at Feishu (BL13) and Xinshu (BL15) with moxa sticks daily for 3 weeks (n = 8); benazepril group (abbreviate as Ben group in F): CHF rats were administered with benazepril at a daily dose of 2 mg/kg for 3 weeks (n = 7); aibei group: CHF rats were administered with benazepril at a daily dose of 2 mg/kg, and performed for 20 min at Feishu (BL13) and Xinshu (BL15) with moxa sticks daily for 3 weeks (n = 9). TUNEL: terminal-deoxynucleoitidyl transferase mediated nick end labeling; CHF: chronic heart failure. aP < 0.01, compared with normal group; bP < 0.01, compared with model group; dP < 0.01, compared with Aibei group.
Figure 3 Comparisons of myocardial cells apoptosis in different groups A-E: TUNEL staining in different groups (×200); F: myocardial cells apoptosis index in different groups. Normal group: rats were fed normally without intervention (n = 10); model group: CHF rats were fed normally without treatment (n = 6); moxibustion group (abbreviate as Mox group in F): CHF rats were performed for 20 min at Feishu (BL13) and Xinshu (BL15) with moxa sticks daily for 3 weeks (n = 8); benazepril group (abbreviate as Ben group in F): CHF rats were administered with benazepril at a daily dose of 2 mg/kg for 3 weeks (n = 7); aibei group: CHF rats were administered with benazepril at a daily dose of 2 mg/kg, and performed for 20 min at Feishu (BL13) and Xinshu (BL15) with moxa sticks daily for 3 weeks (n = 9). TUNEL: terminal-deoxynucleoitidyl transferase mediated nick end labeling; CHF: chronic heart failure. aP < 0.01, compared with normal group; bP < 0.01, compared with model group; dP < 0.01, compared with Aibei group.
Figure 4 Pathological changes of left ventricular myocardial tissue in different groups A-E: HE staining in different groups (×400). → : indicates changes of myocardial cell swelling and cytoplasmic vacuolation; ←: indicates rupture and dissolution of myocardial fiber. Normal group: rats were fed normally without intervention (n = 10); model group: CHF rats were fed normally without treatment (n = 6); moxibustion group: CHF rats were performed for 20 min at Feishu (BL13) and Xinshu (BL15) with moxa sticks daily for 3 weeks (n = 8); benazepril group: CHF rats were administered with benazepril at a daily dose of 2 mg/kg for 3 weeks (n = 7); Aibei group: CHF rats were administered with benazepril at a daily dose of 2 mg/kg, and performed for 20 min at Feishu (BL13) and Xinshu (BL15) with moxa sticks daily for 3 weeks (n = 9). HE: hematoxylin and eosin; CHF: chronic heart failure.
Figure 4 Pathological changes of left ventricular myocardial tissue in different groups A-E: HE staining in different groups (×400). → : indicates changes of myocardial cell swelling and cytoplasmic vacuolation; ←: indicates rupture and dissolution of myocardial fiber. Normal group: rats were fed normally without intervention (n = 10); model group: CHF rats were fed normally without treatment (n = 6); moxibustion group: CHF rats were performed for 20 min at Feishu (BL13) and Xinshu (BL15) with moxa sticks daily for 3 weeks (n = 8); benazepril group: CHF rats were administered with benazepril at a daily dose of 2 mg/kg for 3 weeks (n = 7); Aibei group: CHF rats were administered with benazepril at a daily dose of 2 mg/kg, and performed for 20 min at Feishu (BL13) and Xinshu (BL15) with moxa sticks daily for 3 weeks (n = 9). HE: hematoxylin and eosin; CHF: chronic heart failure.
Figure 5 Comparisons of the expressions of Cyt-C and AIF in different groups A: Cyt-C, AIF and GAPHD protein expression in different groups; 1: normal group; 2: model group; 3: moxibustion group; 4: benazepril group; 5: aibei group; B: the expression level of Cyt-C in different groups; C: the expression level of AIF in different groups. Normal group: rats were fed normally without intervention (n = 10); model group: CHF rats were fed normally without treatment (n = 6); moxibustion group (abbreviate as Mox group in B, C): CHF rats were performed for 20 min at Feishu (BL13) and Xinshu (BL15) with moxa sticks daily for 3 weeks (n = 8); benazepril group (abbreviate as Ben group in B, C): CHF rats were administered with benazepril at a daily dose of 2 mg/kg for 3 weeks (n = 7); Aibei group: CHF rats were administered with benazepril at a daily dose of 2 mg/kg, and performed for 20 min at Feishu (BL13) and Xinshu (BL15) with moxa sticks daily for 3 weeks (n = 9). Cyt-C: cytochrome c; AIF: apoptosis-inducing factor; GAPHD: glyceraldehyde-3-phosphate dehydrogenase; CHF: chronic heart failure. aP < 0.01, compared with normal group; bP < 0.01, compared with model group; cP < 0.05, dP < 0.01, compared with Aibei group.
Figure 5 Comparisons of the expressions of Cyt-C and AIF in different groups A: Cyt-C, AIF and GAPHD protein expression in different groups; 1: normal group; 2: model group; 3: moxibustion group; 4: benazepril group; 5: aibei group; B: the expression level of Cyt-C in different groups; C: the expression level of AIF in different groups. Normal group: rats were fed normally without intervention (n = 10); model group: CHF rats were fed normally without treatment (n = 6); moxibustion group (abbreviate as Mox group in B, C): CHF rats were performed for 20 min at Feishu (BL13) and Xinshu (BL15) with moxa sticks daily for 3 weeks (n = 8); benazepril group (abbreviate as Ben group in B, C): CHF rats were administered with benazepril at a daily dose of 2 mg/kg for 3 weeks (n = 7); Aibei group: CHF rats were administered with benazepril at a daily dose of 2 mg/kg, and performed for 20 min at Feishu (BL13) and Xinshu (BL15) with moxa sticks daily for 3 weeks (n = 9). Cyt-C: cytochrome c; AIF: apoptosis-inducing factor; GAPHD: glyceraldehyde-3-phosphate dehydrogenase; CHF: chronic heart failure. aP < 0.01, compared with normal group; bP < 0.01, compared with model group; cP < 0.05, dP < 0.01, compared with Aibei group.
| 1. |
Parajuli DR, Shakib S, Eng- Frost J, McKinnon RA, Caughey GE, Whitehead D. Evaluation of the prescribing practice of guideline-directed medical therapy among ambulatory chronic heart failure patients. BMC Cardiovascular Disorders 2021; 21: 104.
DOI PMID |
| 2. |
Ding H, Chen SH, Edwards I, Jayasena R, Maiorana A. Effects of different telemonitoring strategies on chronic heart failure care: systematic review and subgroup Meta-analysis. J Med Internet Res 2020; 22: e20032.
DOI URL |
| 3. |
Gommans DHF, Revuelta-Lopez E, Lupon J, et al. Soluble neprilysin and corin concentrations in relation to clinical outcome in chronic heart failure. JACC Heart Fail 2021; 9: 85-95.
DOI URL |
| 4. |
Deng HH, Ouyang WB, Zhang L, Xiao XS, Huang ZY, Zhu WD. LncRNA GASL1 is downregulated in chronic heart failure and regulates cardiomyocyte apoptosis. Cell Mol Biol Lett 2019; 24: 41.
DOI URL |
| 5. |
Gao G, Yu Z, Yan J, et al. Poly (ADP-ribose) polymerase-and cytochrome c-mediated apoptosis induces hepatocyte injury in a rat model of hyperammonia-induced hepatic failure. Mol Med Rep 2015; 11: 4211.
DOI URL |
| 6. |
Mondal NK, Li T, Chen Z, et al. Mechanistic insight of platelet apoptosis leading to non-surgical bleeding among heart failure patients supported by continuous-flow left ventricular assist devices. Mol Cell Biochem 2017; 433: 125-37.
DOI URL |
| 7. |
Hintze M, Griesing S, Michels M, et al. Alopecia in Harlequin mutant mice is associated with reduced AIF protein levels and expression of retroviral elements. Mamm Genome 2021; 32: 12-29.
DOI PMID |
| 8. |
Gordon A, Glickman-Simon R. Moxibustion and breech presentation, breathing exercises and asthma, coenzyme Q10 and heart failure, acupuncture and chronic low back pain, and cinnamon and diabetes. Explore (NY) 2014; 10: 198-202.
DOI URL |
| 9. | Liang B, Yan C, Zhang L, Yang Z, Lu L. The effect of acupuncture and moxibustion on heart function in heart failure patients: a systematic review and Meta-analysis. Evid Based Complement Alternat Med 2019; 2019: 1-13. |
| 10. |
Li H, Duan Y, Chen B, Zhao Y, Lu L. New pharmacological treatments for heart failure with reduced ejection fraction (HFrEF): a Bayesian network Meta-analysis. Medicine (Baltimore) 2020; 99: e18341.
DOI URL |
| 11. | Li QL, Ma Q, Li Y, et al. Effect of moxibustion on cardiac function and expression of autophagy-related proteins of cardiomyocytes in chronic heart failure rats. Zhen Ci Yan Jiu 2020; 45: 259-63. |
| 12. | Liu NN, Jia XZ, Wang J, et al. Moxibustion improves cardiac function by up-regulating autophagy-related proteins of cardiomyocytes in rats with chronic heart failure. Zhen Ci Yan Jiu 2019; 44: 25-30. |
| 13. | Li D, Li QL, Ma Q, et al. Effects of moxibustion on ventricular mass index and expression of apoptosis related proteins in myocardium of rats with chronic heart failure. Zhen Ci Yan Jiu 2018; 43: 80-5. |
| 14. | Wang J, Zeng YL, Wu FQ, et al. Effect of moxibustion stimulation of “Feishu” (BL13) and “Xinshu” (BL15) on expression of myocardial MyD 88 protein and Caspase 3 mRNA in chronic heart failure rats. Zhen Ci Yan Jiu 2016; 41: 429-34. |
| 15. |
Liu Y, Xu W, Xiong Y, et al. Evaluations of the effect of Huangqi against heart failure based on comprehensive echocardiography index and metabonomics. Phytomedicine 2018; 50: 205-12.
DOI URL |
| 16. | Li X, Xie L, He B, Huang W. Improvement and the mechanism of cardiac function by knockdown of ADAM10 in adriamycin-induced cardiomyopathy rats. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2018; 34: 41-6. |
| 17. |
Xu G, Xiao Q, Zhou J, Liang F. Acupuncture and moxibustion for primary osteoporosis: an overview of systematic review. Medicine (Baltimore) 2020; 99: e19334.
DOI URL |
| 18. |
Franconi G, Manni L, Aloe L, et al. Acupuncture in clinical and experimental reproductive medicine: a review. J Endocrinol Invest 2011; 34: 307-11.
DOI PMID |
| 19. |
Jia Q, Wang L, Zhang X, et al. Prevention and treatment of chronic heart failure through Traditional Chinese Medicine: role of the gut microbiota. Pharmacol Res 2020; 151: 104552.
DOI URL |
| 20. | Xin JJ, Zhao YX, Liu Q, et al. New thoughts about study on cholinergic anti-inflammatory pathway in mediating delaying effect of electroacupuncture on myocardial remodeling of chronic hypertension. Zhen Ci Yan Jiu 2020; 45: 762-6. |
| 21. |
Abdi H, Tayefi M, Moallem SR, et al. Abdominal and auricular acupuncture reduces blood pressure in hypertensive patients. Complement Ther Med 2017; 31; 20-6.
DOI URL |
| 22. |
Häggström J, Boswood A, O'Grady M, et al. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study. J Vet Intern Med 2008; 22: 1124-35.
DOI PMID |
| 23. |
Sica DA, Carter B, Cushman W, Hamm L. Thiazide and loop diuretics. J Clin Hypertens (Greenwich) 2011; 13: 639-43.
DOI URL |
| 24. |
King JN, Martin M, Chetboul V, et al. Evaluation of benazepril in cats with heart disease in a prospective, randomized, blinded, placebo-controlled clinical trial. J Vet Intern Med 2019; 33: 2559-71.
DOI URL |
| 25. | Xie XJ, Li CQ. Chrysophanol protects against acute heart failure by inhibiting JNK1/2 pathway in rats. Med Sci Monit 2020; 26: e926392. |
| 26. |
Rodríguez-Feo JA, Fortes J, Aceituno E, et al. Doxazosin modifies Bcl-2 and Bax protein expression in the left ventricle of spontaneously hypertensive rats. J Hypertens 2000; 18: 307-15.
PMID |
| 27. | Gao G, Chen W, Yan M, et al. Rapamycin regulates the balance between cardiomyocyte apoptosis and autophagy in chronic heart failure by inhibiting mTOR signaling. Int J Mol Med 2020; 45: 195-209. |
| 28. |
Takemura G, Kanamori H, Okada H, et al. Anti-apoptosis in nonmyocytes and pro-autophagy in cardiomyocytes: two strategies against postinfarction heart failure through regulation of cell death/degeneration. Heart Fail Rev 2018; 23: 759-72.
DOI PMID |
| 29. |
Gustafsson AB, Gottlieb RA. Heart mitochondria: gates of life and death. Cardiovasc Res 2008; 77: 334-43.
DOI PMID |
| 30. |
Regula KM, Kirshenbaum LA. Apoptosis of ventricular myocytes: a means to an end. J Mol Cell Cardiol 2005; 38: 3-13.
PMID |
| 31. |
Estaquier J, Vallette F, Vayssiere JL, Mignotte B. The mitochondrial pathways of apoptosis. Adv Exp Med Biol 2012; 942: 157-83.
DOI PMID |
| 32. |
Huang JT, Chang LC, Cheng CS, et al. Cytotoxicity produced by Silicate Nanoplatelets: study of cell death mechanisms. Toxins (Basel) 2020; 12: 623.
DOI URL |
| 33. |
Yim J, Cho H, Rabkin SW. Gene expression and gene associations during the development of heart failure with preserved ejection fraction in the Dahl salt sensitive model of hypertension. Clin Exp Hypertens 2018; 40: 155-66.
DOI URL |
| 34. |
Nagakannan P, Islam MI, Karimi-Abdolrezaee S, Eftekharpour E. Inhibition of VDAC1 protects against glutamate-induced oxytosis and mitochondrial fragmentation in hippocampal HT22 cells. Cell Mol Neurobiol 2019; 39: 73-85.
DOI PMID |
| 35. | Pop C, Ștefan MG, Muntean DM, et al. Protective effects of a discontinuous treatment with alpha-lipoic acid in obesity-related heart failure with preserved ejection fraction in rats. Antioxidants (Basel, Switzerland) 2020; 9: 1073. |
| 36. |
Wang J, Zeng YL, Wang J, et al. Observation on clinical effects of moxibustion therapy plus medications for chronic heart failure. J Acupunct Tuina Sci 2012; 10: 349-354.
DOI URL |
| 37. | Maries L, Manitiu I. Diagnostic and prognostic values of B-type natriuretic peptides (BNP) and N-terminal fragment brain natriuretic peptides (NT-pro-BNP): review. Diabetes Vasc Dis Re 2016; 13: 286-9. |
| [1] | TIAN Xinrong, HOU Runsu, LIU Xinguang, ZHAO Peng, TIAN Yange, LI Jiansheng. Yangqing Chenfei formula (养清尘肺方) alleviates crystalline silica induced pulmonary inflammation and fibrosis by suppressing macrophage polarization [J]. Journal of Traditional Chinese Medicine, 2023, 43(6): 1126-1139. |
| [2] | LI Chaoran, YANG Yan, FENG Chuwen, LI Heng, QU Yuanyuan, WANG Yulin, WANG Delong, WANG Qingyong, GUO Jing, SHI Tianyu, SUN Xiaowei, WANG Xue, HOU Yunlong, SUN Zhongren, YANG Tiansong. Integrated 'omics analysis for the gut microbiota response to moxibustion in a rat model of chronic fatigue syndrome [J]. Journal of Traditional Chinese Medicine, 2023, 43(6): 1176-1189. |
| [3] | WANG Miao, ZHU Yan, ZHAO Hui, ZHAO Hongfang. Moxibustion enables protective effects on rheumatoid arthritis-induced myocardial injury via transforming growth factor beta1 signaling and metabolic reprogramming [J]. Journal of Traditional Chinese Medicine, 2023, 43(6): 1190-1199. |
| [4] | CHEN Yunhu, YIN Moqing, FAN Lihua, JIANG Xuechun, ZHANG Tao, ZHU Xingyu, XU Hongfeng. Mirror-like tongue is an important predictor of acute heart failure: a cohort study of acute heart failure in Chinese patients [J]. Journal of Traditional Chinese Medicine, 2023, 43(6): 1243-1251. |
| [5] | LI Xingjie, LIU Qiqi, XIA Rui, LIU Jun, WANG Dan, SHI Jiao, KUANG Yuxing, DAI Yalan, HUANG Haoyu, TANG Wei, CHEN Shangjie. Moxibustion modulates working memory in patients with amnestic mild cognitive impairment: a functional magnetic resonance imaging study [J]. Journal of Traditional Chinese Medicine, 2023, 43(4): 801-808. |
| [6] | MA Fangfang, ZHANG Hewei, LI Bingxue, CHENG Peiyu, YU Mingwei, WANG Xiaomin. Acupuncture and moxibustion for malignant tumor patients with psychological symptoms of insomnia, anxiety and depression: a systematic review and Meta-analysis [J]. Journal of Traditional Chinese Medicine, 2023, 43(3): 441-456. |
| [7] | MIN Youjiang, YAO Haihua, WANG Zhiqin, LUO Kaitao, SUN Jie, YUAN Zheng, WU Huiqi, CHENG Lihong. Efficacy of suspended moxibustion stimulating Shenshu (BL23) and Guanyuan (CV4) on the amygdala-HPA axis in rats with kidney-Yang deficiency symptom pattern induced by hydrocortisone [J]. Journal of Traditional Chinese Medicine, 2023, 43(1): 113-123. |
| [8] | YAO Yao, ZHAO Zhenni, CHEN Fengqin, LENG Yufei, PANG Xiangtian, XU Xiao, SUN Zhiling. Effectiveness of moxibustion alone on lumbar disc herniation: a Meta-analysis of randomized controlled trials [J]. Journal of Traditional Chinese Medicine, 2023, 43(1): 14-26. |
| [9] | YANG Jun, XIONG Jun, XU Shaozhong, XIE Hongwu, XIANG Jie. Effect and cerebral mechanism of moxibustion at heat-sensitized Yaoyangguan (GV3) in patients with lumbar disc herniation and myofascial pain syndrome by resting-state functionality magnetic resonance imaging: protocol for an observational study [J]. Journal of Traditional Chinese Medicine, 2023, 43(1): 175-180. |
| [10] | ZHU Lingyan, WEI Yihong, WANG Youhua, YANG Jianmei, LI Jiawei, CAO Min, ZHOU Duan. Protective efficacy of Shenge San (参蛤散) on mitochondria in H9c2 cardiomyocytes [J]. Journal of Traditional Chinese Medicine, 2022, 42(6): 892-899. |
| [11] | FANG Jing, PAN Wen, WANG Xiangyun, LI Fengxing, ZHAO Ling, HUANG Zouqin, SHEN Xueyong. Efficacy of stimulating Mingmen (GV4) and Guanyuan (CV4) on kidney Yang deficiency in rat model: laser irradiation vs traditional moxibustion [J]. Journal of Traditional Chinese Medicine, 2022, 42(6): 972-979. |
| [12] | ZHOU Haiyan, ZHONG Yumei, GAO Xiuhua, WU Fei, JIA Min, YANG Xin. Efficacy of Moxa-burning heat stimulating Zusanli (ST36) and Shenshu (BL23) on expressions of macrophage migration inhibitory factor and macrophage apoptosis in rabbits with adjuvant-induced arthritis [J]. Journal of Traditional Chinese Medicine, 2022, 42(6): 980-987. |
| [13] | ZHANG Jiaying, WEI Xiangxiang, LI Xuefeng, YUAN Yang, DOU Yinghuan, SHI Yanbin, XIE Ping, ZHOU Mengru, ZHAO Junnan, LI Miao, ZHANG Shuwen, ZHU Rui, TIAN Ying, TAN Hao, TIAN Feifei. Shunxin decoction (顺心组方) improves diastolic function in rats with heart failure with preserved ejection fraction induced by abdominal aorta constriction through cyclic guanosine monophosphate-dependent protein kinase Signaling Pathway [J]. Journal of Traditional Chinese Medicine, 2022, 42(5): 764-772. |
| [14] | CHEN Yunhu, FAN Lihua, ZHANG Tao, LIU Xueqian. Effectiveness of Zhuling decoction (猪苓汤) on diuretic resistance in patients with heart failure: a randomized, controlled trial [J]. Journal of Traditional Chinese Medicine, 2022, 42(3): 439-445. |
| [15] | MA Tingting, WU Jie, YANG Lijie, FENG Fen, YANG Huilin, ZHANG Jinhua, ZHONG Yanjin, NING Qing, HUANG Lirong, LIN Youbing, YAN Jue, CHEN Guiquan, HOU Tianshu, WANG Li, REN Yuanfang, TAN Jing. Ginger-indirect moxibustion plus acupuncture versus acupuncture alone for chronic fatigue syndrome: a randomized controlled trial [J]. Journal of Traditional Chinese Medicine, 2022, 42(2): 242-249. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
